H3N2 Influenza Group A RNA Detection Qualitative Test
Introduction
The H3N2 Influenza Group A RNA Detection Qualitative Test is a vital diagnostic tool used to identify the presence of the H3N2 strain of the influenza virus. This test is particularly important during flu season, as it helps healthcare providers make informed decisions regarding patient care. Utilizing advanced Real Time PCR technology, the test provides rapid and accurate results, enabling timely treatment and management of influenza cases.
What the Test Measures
This test specifically measures the RNA of the H3N2 influenza virus in respiratory specimens. By detecting viral RNA, healthcare providers can determine if a patient is currently infected with the H3N2 strain of the influenza virus, facilitating appropriate treatment options.
Who Should Consider This Test
Individuals who are experiencing flu-like symptoms such as fever, cough, sore throat, body aches, and fatigue should consider this test. Additionally, those who have been in close contact with confirmed influenza cases or are at higher risk of complications, such as the elderly or those with underlying health conditions, should also seek testing.
Benefits of Taking the Test
- Accurate identification of H3N2 influenza virus infections.
- Timely diagnosis leading to prompt treatment and management.
- Helps prevent the spread of influenza in the community.
- Provides peace of mind for patients and their families.
Understanding Your Results
Results from the H3N2 Influenza Group A RNA Detection Qualitative Test will indicate whether the H3N2 virus is detected or not. A positive result confirms an active infection, while a negative result suggests that the virus is not present at the time of testing. It is important to discuss results with a healthcare provider for appropriate follow-up and care.
Test Name and Price
| Test Name | Discount Price | Regular Price |
|---|---|---|
| H3N2 Influenza Group A RNA Detection Qualitative Test | 17680 KSh | 20800 KSh |
Branches and Booking
We have branches across Kenya, including major cities such as Nairobi and Mombasa, making it convenient for you to access our services. To book the H3N2 Influenza Group A RNA Detection Qualitative Test, please contact us via phone or WhatsApp at +254711564616. Our team is ready to assist you with the booking process.
Pre-Test Instructions
Before taking the test, patients are required to sign a consent document and bring any relevant clinical history related to H3N2 and influenza. Sample types accepted include deep nostrils (nasal swab), nasopharynx (nasopharyngeal swab), nasopharyngeal aspirate, throat, or bronchial aspirate.
Conclusion
The H3N2 Influenza Group A RNA Detection Qualitative Test is an essential diagnostic tool for identifying influenza infections. With a straightforward booking process and accessible locations, DNA Labs Kenya is committed to providing reliable and timely testing services for all patients.
